1996

• K. Yamaguchi-Takihara, H. Hirota, K. Kunisada, H. Matsui, Y. Fujino, T. Taga, and T. Kishimoto. Roles of gp130 singaling pathways in cardiac myocytes: Recent advances and implications for cardiovasculra disease. J. Cardiac Failure 2:S63-68, 1996.
• T. Taga, and T. Kishimoto. Signal transduction through class I cytokine receptors. In Modular Texts in Molecular and Cell Biology edt by C.-H. Heldin and M. Purton, Chapman and Hall Ltd. (London). p19-36, 1996.
• S. Tajima, K. Tsuji, Y. Ebihara, X. Sui, R. Tanaka, K. Muraoka, M. Yoshida, K. Yamada, K. Yasukawa, T. Taga, T. Kishimoto, and T. Nakahata. Analysis of IL-6 receptor and gp130 expressions and proliferative capability of human CD43+ cells. J. Exp. Med. , 184:1357-1364, 1996.
• V. C. Broudy, N. L. Lin, N. Fox, T. Taga, M. Saito, and K. Kaushansky. Thrombopoietin stimulates CFU-Meg proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood , 88:2026-2032, 1996.
• D. Watanabe, R. Yoshimura, M. Khalil, K. Yoshida, T. Kishimoto, T. Taga, and H. Kiyama. Characteristic localization of gp130 (the signal transducing receptor component used in common for IL-6/ IL-11/ CNTF/ LIF/ OSM) in the rat brain. Eur. J. Neurosci. , 8:1630-1640, 1996.
• K. Ikeda, M. Kinoshita, N. Tagaya, T. Shiojima, T. Taga, K. Yasukawa, H. Suzuki, and A. Okano. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res. , 726:91-7, 1996.
• J. Nichols, D. Davidson, T. Taga, K. Yoshida, I. Chambers, and A. Smith. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech. Dev. , 57:123-131, 1996.
• T. Taga, gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem. , 67:1-10, 1996.
• H. Hirota, H. Kiyama, T. Kishimoto, and T. Taga . Accelerated nerve regeneration in mice by upregulated expression of IL-6 and IL-6 receptor after trauma. J. Exp. Med. , 183:2627-2634, 1996.
• E. Romas, N. Udagawa, H. Zhou, T. Tamura, M. Saito, T. Taga, D. J. Hilton, T. Suda, K. W. Ng, and T. J. Martin. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. Exp. Med. , 183:2581-2591, 1996.

• U. Koshimizu, T. Taga, M. Watanabe, M. Saito, Y. Shirayoshi, T. Kishimoto, and N. Nakatsuji. Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells. Development , 122:1235-1242, 1996.
• H. Hirota, K. Yoshida, T. Taga, and T. Kishimoto. gp130 signaling pathways: recent advances and implications for cardiovascular disease. Trends Cardiovasc. Med. , 6:109-115, 1996.
• H. Shibayama, S. Tagawa, H. Hattori, K. Harigaya, T. Taga, T. Machii, and T. Kitani. Interleukin-6 inhibits the chemotaxis of human malignant plasma cell lines. Brit. J. Hematol. , 93:534-541, 1996.
• X. Sui, K. Tsuji, S. Tajima, R. Tanaka, K. Muraoka, Y. Ebihara, K. Ikebuchi, K. Yasukawa, T. Taga, T. Kishimoto, and T. Nakahata. Erythropoietin-independent erythrocyte production: Signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells. J. Exp. Med. , 183:837-845, 1996.
• K. C. Wollert, T. Taga, M. Saito, M. Narazaki, T. Kishimoto, C. C. Glembotski, A. B. Vernallis, J. K. Heath, D. Pennica, W. I. Wood, and K. R. Chien. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy: Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor dependent pathways. J. Biol. Chem. , 271:9535-9545, 1996.
• K. Murakami-Mori, T. Taga, T. Kishimoto, and Nakamura, S. Soluble form of IL-6 receptor (sIL-6Ra) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells and soluble form of gp130 is antagonistic for sIL-6Ra-induced AIDS-KS cell growth. Int. Immunol. , 8:595-602, 1996.
• T. Nakahata, X. Sui, S. Tajima, K. Tsuji, K. Yasukawa, T. Taga, and T. Kishimoto. Ex vivo expansion of human primitive hemopoietic progenitors. In Bone Marrow Transplantation---Basic and Clinical Studies. edt. by S. Ikehara, F. Takaku, and R. A. Good. Springer-Verlag (Tokyo). p.47-63, 1996.
• T. Taga, K. Yoshida, H. Hirota, and T. Kishimoto. Physiological and pathological role of gp130, a common signal transducer for IL-6-family of cytokines. In Bone Marrow Transplantation---Basic and Clinical Studies. edt. by S. Ikehara, F. Takaku, and R. A. Good. Springer-Verlag (Tokyo). p.101-109, 1996.
• K. Yoshida, T. Taga, M. Saito, S. Suematsu, A. Kumanogoh, T. Tanaka, H. Fujiwara, M. Hirata, T. Yamagami, T. Nakahata, T. Hirabayashi, Y. Yoneda, K. Tanaka, W.-Z. Wang, C. Mori, K. Shiota, N. Yoshida, and T. Kishimoto. Targeted disruption of gp130, a common signal transducer for IL-6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA , 93:407-411, 1996.
• Y. Inoue, T. Kagawa, Y. Matsumura, K. Ikenaka, and K. Mikoshiba Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci Res 25 : 161-172 1996.
• M. Yamada, T. Kagawa, and K. Ikenaka Development and differentiation of oligodendrocytes. Jpn J Physiol 46 : 105-110 1996.
• T. Kagawa, A. Oba, S. Okumura, and K. Ikenaka Localization of mRNA for UDP-galactose: ceramide galactosyltransferase in the brain during mouse development. Dev Neurosci 18 : 309-318 1996.